9 Meters Biopharma is a clinical-stage biopharmaceutical company that devotes itself to rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. They are currently in various phases of clinical trials for multiple drugs, including Larazotide for celiac disease and multi-system inflammatory syndrome and Vurolenatide for short bowel syndrome. The company is also developing other proprietary drugs, such as NM-102, NM-003, NM-136, and NM-004 to treat obesity disorders and rare/orphan indications.